tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Crohn Disease D003424 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Thyroid Diseases D013959 8 associated lipids
Sinusitis D012852 9 associated lipids
Leukocytosis D007964 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypoglycemia D007003 13 associated lipids
Hemolytic-Uremic Syndrome D006463 2 associated lipids
Pancytopenia D010198 6 associated lipids
Nervous System Diseases D009422 37 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Brain Edema D001929 20 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Gingivitis D005891 3 associated lipids
Periodontal Pocket D010514 9 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Ischemia D007511 18 associated lipids
Glycosuria D006029 10 associated lipids
Seizures D012640 87 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Haas M et al. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. 1999 Am. J. Kidney Dis. pmid:10401019
Katayama Y [Current tendency in treatment for acute ischemic stroke]. 1999 Nippon Ika Daigaku Zasshi pmid:10401232
Tada H et al. Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats. 1999 Pharmacol. Toxicol. pmid:10401724
Timmermann W et al. Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. 1999 Transplantation pmid:10401762
Banerjee C et al. Ca2+ and calmodulin-dependent protein phosphatase from Leishmania donovani. 1999 Parasitology pmid:10406035
Kaibori M et al. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. 1999 J. Hepatol. pmid:10406194
Hebert MF and Lam AY Diltiazem increases tacrolimus concentrations. 1999 Ann Pharmacother pmid:10410178
Rhew JH et al. Induction of fibronectin gene expression by inhibitors of protein phosphatase type 2B in normal and transformed fibroblasts. 1999 Exp. Mol. Med. pmid:10410305
Muegge I et al. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. 1999 J. Med. Chem. pmid:10411471
Varghese Z et al. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. 1999 Kidney Int. Suppl. pmid:10412758
Przepiorka D et al. Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. 1999 Bone Marrow Transplant. pmid:10414918
Bavetta S et al. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. 1999 Exp. Neurol. pmid:10415144
Kuroda S et al. The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. 1999 Brain Res. pmid:10415369
Finn WF FK506 nephrotoxicity. 1999 May-Jul Ren Fail pmid:10416209
Min DI et al. Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient. 1999 Pharmacotherapy pmid:10417040
Mrowietz U Macrolide immunosuppressants. 1999 Jul-Aug Eur J Dermatol pmid:10417434
Remitz A et al. Tacrolimus ointment improves psoriasis in a microplaque assay. 1999 Br. J. Dermatol. pmid:10417522
Dalvit C et al. Use of organic solvents and small molecules for locating binding sites on proteins in solutions. 1999 J. Biomol. NMR pmid:10419292
Dunn SE et al. Calcineurin is required for skeletal muscle hypertrophy. 1999 J. Biol. Chem. pmid:10419511
Becker JW et al. 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. 1999 J. Med. Chem. pmid:10425089
Kato K et al. Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition. 1999 Neuroscience pmid:10426482
Pirenne J Contribution of large animal models to the development of clinical intestinal transplantation. 1999 Apr-Jun Acta Gastroenterol. Belg. pmid:10427786
Jamieson NV Adult small intestinal transplantation in Europe. 1999 Apr-Jun Acta Gastroenterol. Belg. pmid:10427790
Kahan BD An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy. 1999 Transplantation pmid:10428260
Reichenspurner H et al. Optimization of the immunosuppressive protocol after lung transplantation. 1999 Transplantation pmid:10428269
Soccal PM et al. Improvement of drug-induced chronic renal failure in lung transplantation. 1999 Transplantation pmid:10428288
Levy GA Neoral/cyclosporine-based immunosuppression. 1999 Liver Transpl Surg pmid:10431016
Pollock R and Rivera VM Regulation of gene expression with synthetic dimerizers. 1999 Meth. Enzymol. pmid:10432459
Shinkura N et al. Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases. 1999 Autoimmunity pmid:10433096
Briggs WA et al. Lymphocyte suppression by rolipram with other immunosuppressive drugs. 1999 J Clin Pharmacol pmid:10434230
Harikrishnan P and Harden PN Tacrolimus can resolve cyclosporin-induced gingival hyperplasia. 1999 Nephrol. Dial. Transplant. pmid:10435907
Tsuji Y et al. Effects of cyclosporin A, FK506 and steroid hormones on hair growth. 1999 Exp. Dermatol. pmid:10439282
Sheikh AM et al. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. 1999 Transplantation pmid:10440408
Moxey-Mims MM Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) 1999 Transplantation pmid:10440413
Magee CC et al. Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil. 1999 Clin. Nephrol. pmid:10442495
Kur F et al. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation. 1999 Thorac Cardiovasc Surg pmid:10443520
Uchiyama H et al. Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model. 1999 Immunology pmid:10447745
Volbracht C et al. ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. 1999 Mol. Med. pmid:10449809
Goulet MT et al. C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length study. 1999 Bioorg. Med. Chem. Lett. pmid:10450986
Armstrong HM et al. Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity. 1999 Bioorg. Med. Chem. Lett. pmid:10450987
Penson MG et al. Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. 1999 J. Heart Lung Transplant. pmid:10452348
Jones JW et al. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. 1999 Surgery pmid:10455910
Miura S et al. The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. 1999 Transplant. Proc. pmid:10455940
Jiang H and Kobayashi M Differences between cyclosporin A and tacrolimus in organ transplantation. 1999 Transplant. Proc. pmid:10455942
Kobashigawa JA Postoperative management following heart transplantation. 1999 Transplant. Proc. pmid:10455966
Hachida M et al. Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. 1999 Transplant. Proc. pmid:10455968
Van Gelder RN and Kaplan HJ Immunosuppression in uveitis therapy. 1999 Springer Semin. Immunopathol. pmid:10457590
Drachenberg CB et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. 1999 Transplantation pmid:10459544
Burke GA et al. The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy. 1999 Pediatr. Nephrol. pmid:10460501
Morris-Stiff GJ et al. Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: results of an observational study. 1999 Transpl. Int. pmid:10460877